Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The funding sources had no input in the design and conduct of this study, in the collection, analysis and interpretation of the data or in the preparation, review or approval of the manuscript
Pharmacologic GLP-1s were originally developed for type II diabetes, where they effectively lower HbA1c (hemoglobin A1c, typically by 11.5%) and often promote weight loss of 510% in diabetics
Compared to IGF-1 LR3, growth hormone therapy has been studied much more extensively, and a considerable amount of evidence supports its effectiveness in increasing lean muscle mass and improving quality of life
Patients should speak to their GP about local eligibility criteria
For full functionality of this site it is necessary to enable JavaScript.Here are theinstructions how to enable JavaScript in your web browser.
